JTN Medical Expands Overseas Market, Leading The Innovation Trend Of Medical Instruments
Development History
Origin and Early Exploration: The company's history can be traced back to the 1960s and 1970s. At that time, it took the lead in successfully developing a medical ultrasonic diagnostic instrument, becoming one of the birthplaces of domestic medical ultrasonic instruments. Since then, JTN Medical has continuously delved deep into the field of medical instruments, accumulating rich technical experience and professional knowledge.
Formal Establishment and Initial Development: On March 27, 2006, Wuhan JTN Medical Instrument Development Co., Ltd. was formally established and obtained the "Medical Device Production Enterprise License" issued by the Hubei Food and Drug Administration. In the same year, the company's "Digital Electronic Colposcope", "Male Sexual Function Rehabilitation Therapy Instrument", and "Red Light Therapy Instrument" all passed clinical verification in Wuhan General Hospital of Guangzhou Military Region and Affiliated Hospital of Hubei Hospital of Traditional Chinese Medicine and were successfully registered.
Technological Innovation and Product Expansion: In September 2007, the "JTN-300 Series Intrauterine Cavity Ultrasound Guiding System" passed clinical verification and was successfully registered in February 2008. In June 2008, the company smoothly passed quality certification systems such as ISO9001-2000 and ISO13485-2003. Since then, the company has continuously increased its R & D investment, gathering a large number of outstanding professionals covering multiple disciplines and cooperating sincerely with well-known domestic and foreign ultrasound experts, senior engineers in electronics and computer technology. Multiple products such as the retractable and rotatable ultrasound probe, male sexual function rehabilitation therapy instrument, superconducting gynecological diagnosis and treatment bed, etc. have obtained national utility model patent certificates. It has successively developed high-end medical device products such as high-grade male sexual function rehabilitation therapy instruments, series of intrauterine cavity ultrasound guiding instruments, electronic digital colposcopes, red-blue photon therapy instruments.
Brand Building and Market Recognition: In September 2008, the company was rated as a "National AAA-level Enterprise in Quality, Credit, and Innovation" by the National Brand Committee Quality Professional Committee. In February 2009, it became the preferred enterprise to settle in the "Wuhan National Bio-industry Base (i.e., 'Optics Valley Bio-city')" and successfully registered the "Nine-headed Bird" trademark in May of the same year. In May 2010, it was rated as a "Top 100 Enterprise in Hubei Province" by the Hubei Provincial People's Government. In June 2011, it was rated as an "A-level Tax-paying Enterprise" by the Hubei Provincial Taxation Bureau, continuously enhancing its brand awareness and market influence.
Diversified Development and Market Expansion: In June 2012, the company entered the home health care market, obtained strong government support, and achieved great success. In recent years, JTN Medical has accelerated the pace of overseas market layout, actively participating in various international medical device exhibitions and academic exchange activities, and establishing extensive cooperative relationships with distributors, medical institutions, and professional purchasers around the world. Its products have successfully entered the markets of multiple countries and regions, including Europe, America, Southeast Asia, the Middle East, etc., attracting high attention and favorable comments from local customers.
Technological Innovation Drives Development
The company has always adhered to technological innovation as the core driving force, continuously increasing R & D investment and striving to create high-quality and high-performance medical instruments. After years of unremitting efforts, JTN Medical has a professional R & D team. They conduct in-depth research in the interdisciplinary field of medicine and engineering, constantly exploring new technologies, new materials, and new design concepts, providing a solid technical support for product upgrading and innovative development. Currently, the company's product line covers multiple categories of medical instruments, including but not limited to advanced diagnostic equipment, treatment instruments, and rehabilitation assistive devices. These products have not only been widely recognized in the domestic market but also gradually emerged in the international market with their excellent quality and performance.
Strict Quality Control System
While pursuing technological innovation, JTN Medical attaches great importance to product quality and has established a strict quality control system. From raw material procurement to every production process, it strictly follows international quality management standards to ensure that each medical instrument leaving the factory meets or even exceeds the quality level of international similar products. The company is equipped with advanced production equipment and testing instruments, introduced a refined production management process, and carried out full-process quality monitoring of products, thereby ensuring the reliability and stability of products. This persistent pursuit of quality has enabled Nine-headed Bird Medical's products to win a good reputation in the international market, further enhancing the company's brand image and reputation in the international market.
Future Outlook
With the continuous development of the global medical market and the increasing demand for high-quality medical instruments, JTN Medical Instrument Development Co., Ltd. will continue to adhere to the business philosophy of "Technological Innovation, Quality First, Global Service", continuously increase R & D investment, improve product quality and service level, and further expand overseas market share. The company plans to launch more innovative and competitive medical instrument products in the next few years to meet the needs of different customer levels and make greater contributions to the development of the global medical cause.
